Eberhard Standl
- Endocrinology, Diabetes and Metabolism top 0.05%
- Diabetes Treatment and Management 82
- Diabetes Management and Research 64
- Diabetes, Cardiovascular Risks, and Lipoproteins 30
-
- Cardiovascular Function and Risk Factors 27
- Transplantation top 2%
- Surgery top 1%
- Pancreatic function and diabetes 25
- Pharmacology top 1%
-
- Metabolism, Diabetes, and Cancer 35
-
- Diabetes and associated disorders 31
-
- Diet and metabolism studies 19
Eberhard Standl
202 papers receiving 8.8k citations
Hit Papers
Peers
Comparison fields: 5 of 152
- Endocrinology, Diabetes and Metabolism 6.0k
- Cardiology and Cardiovascular Medicine 2.1k
- Transplantation 169
- Surgery 2.4k
- Pharmacology 663
Countries citing papers authored by Eberhard Standl
This map shows the geographic impact of Eberhard Standl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eberhard Standl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eberhard Standl more than expected).
Fields of papers citing papers by Eberhard Standl
This network shows the impact of papers produced by Eberhard Standl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eberhard Standl. The network helps show where Eberhard Standl may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eberhard Standl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 4 | |
| 3 | 2023 | 9 | |
| 4 | 2020 | 12 | |
| 5 | 2020 | 57 | |
| 6 | 2020 | 2 | |
| 7 | 2019 | 36 | |
| 8 | The global epidemics of diabetes in the 21st century: Current situation and perspectivesbreakdown → | 2019 | 309 |
| 9 | 2018 | 49 | |
| 10 | 2018 | 23 | |
| 11 | 2018 | 2 | |
| 12 | 2017 | 53 | |
| 13 | Assessing the safety of sitagliptin in elderly participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) | 2016 | 1 |
| 14 | 2012 | 41 | |
| 15 | 2007 | 0 | |
| 16 | 2002 | 10 | |
| 17 | 1997 | 15 | |
| 18 | 1997 | 3 | |
| 19 | 1995 | 57 | |
| 20 | Muscle metabolism during rest and exercise: influence on the oxygen transport system of blood in normal and diabetic subjects. | 1976 | 10 |
About Eberhard Standl
Eberhard Standl is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Physiology, Genetics and Surgery, having authored 210 papers that have together received 9.2k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (82 papers), Diabetes Management and Research (64 papers), Metabolism, Diabetes, and Cancer (35 papers), Diabetes and associated disorders (31 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (30 papers), Cardiovascular Function and Risk Factors (27 papers), Pancreatic function and diabetes (25 papers) and Diet and metabolism studies (19 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (6.0k citations), Cardiology and Cardiovascular Medicine (2.1k citations), Transplantation (169 citations), Surgery (2.4k citations) and Pharmacology (663 citations). Eberhard Standl has collaborated with scholars based in Germany, Italy and United States. Frequent co-authors include Oliver Schnell, Lars Rydén, Antonio Ceriello, Darren K. McGuire, Rury R. Holman, Eric D. Peterson, Jennifer B. Green, John B. Buse, Paul W. Armstrong and John M. Lachin. Their work appears in journals such as Diabetes Care, Diabetologia, Diabetes, Cardiovascular Diabetology and Diabetic Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.